Track the 幸康 stock price and the full directors' dealings record of the company, a listed equity based in Taiwan. Shares are listed on the TW market, under the supervision of TWSE / TPEx (MOPS). Market capitalisation: €3bn. The latest transaction was disclosed on 27 April 2026 (Gift). Among the most active insiders: 呂惠清. Every trade is free.
6
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 6,096 of 29,063 companies
66.2
score / 100
Value
63
Quality
69
FCF yld5.8%
Earn yld5.7%
EV/EBITDA11.2x
ROE11%
Gross mgn36%
Net mgn11%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
幸康 es una empresa que cotiza en el mercado XTAI, especializada en el sector de la salud. Se centra en el desarrollo de soluciones innovadoras para mejorar el bienestar del paciente.